Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES for SSI Prevention in Breast Reduction
NCT01538173Phase 4Completed
- Start
- Jan 2007
- Primary completion
- Oct 2011
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetastarch in surgical site infection (SSI). Started Jan 2007; status: completed.
02
Drugs
hetastarch
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01538173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538173.